NCT00255801 2018-08-16
Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
4 trialsNCT00660231 2014-12-03
GemBex
University College, London
Phase 2 Completed
NCT00030589 2013-12-18
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00030849 2013-04-04
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed